[Statins in the secondary prevention of ictus in the community].
Castilla-Guerra
Luis
L
Servicio de Medicina Interna, Hospital de La Merced, Osuna, Sevilla, Spain. castillafernandez@hotmail.com
Balbuena García
Manuel
M
Fernández-Moreno
María Carmen
MC
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D050171:Dyslipidemias / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015994:Incidence; D002546:Ischemic Attack, Transient / Q000453:epidemiology / Q000517:prevention & control*; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D019821:Simvastatin / Q000008:administration & dosage / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D020521:Stroke / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D002784:Cholesterol; D019821:Simvastatin